Antibiotic and Antiviral Prescribing for Long‐Term Care Residents With a COVID‐19 Diagnosis, March 2020–July 2023

The Centers for Disease Control and Prevention oversaw all aspects of the study and directly determined the design, methods, analysis, and preparation. T.C.S. is employed by Chenega Enterprise Systems and Solutions and is assigned to the U.S. Centers for Disease Control and Prevention as part of a contract covering multiple tasks and positions, which do not involve the production, sale, manufacturing, or distribution of vaccines, antibiotics, or antivirals. The other authors declare no conflicts of interest. These data are not publicly available. Table S1: Lists the International Classification of Diseases, 10th Revision (ICD-10) diagnosis codes used to evaluate a diagnosis of bacterial pneumonia co-infection in residents with COVID-19 and pneumonia due to coronavirus disease 2019. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.